WebNov 15, 2024 · UCARTCS1 cells are "off the shelf" allogeneic CAR T-cells derived from healthy donors targeting CS1 (SLAMF7), which is a highly attractive target, due to its overexpression on MM cells. Furthermore, the genes coding for the TCRα chain of the TCRab receptor and for CS1 are disrupted in UCARTCS1 cells using Cellectis' TALEN® … Our in vivo study demonstrated that rationally optimized BCMA/CS1 OR-gate CAR-T cells are uniquely capable of controlling heterogeneous MM that proves resistant to single-input BCMA or CS1 CAR-T ...
Biomedicines Free Full-Text Novel CS1 CAR-T Cells and ... - MDPI
WebOUTLINE: This is a dose-escalation study of CS1-CAR T cells. Patients undergo leukapheresis over 2-4 hours. Beginning 3-4 weeks, patients receive cyclophosphamide intravenously (IV) on days -4 and/or -3 or fludarabine IV and cyclophosphamide IV on days-5 to -3. Patients then undergo CS1-CAR T therapy over 10 WebMay 8, 2024 · High-throughput generation and screening of BCMA/CS1 OR-gate CARs. a A vertically integrated optimization process for CAR-T cell therapy development.b Schematic of a single-chain bispecific (OR-gate) CAR, which contains two ligand-binding domains connected in tandem. A panel of CAR variants was constructed from two CS1-binding … hdfc e verify income tax
Genetic modification of T cells redirected toward CS1 enhances …
WebNov 15, 2024 · CS1 plays a vital role in myeloma pathogenesis, and is also highly expressed on tumor cells in almost all patients (pts) with multiple myeloma (MM). Therefore, we aim … WebApr 14, 2024 · Targeting alternative myeloma-expressed proteins with CAR-T therapy has the potential to improve patient outcomes. CS1 (SLAMF7, CRACC) is a rational target for … WebMM. CD19- targeted CAR T cells in conjunction with autologous stem cell transplantation also showed activity in RRMM. Dual- target CAR T cells are in clinical trials for RRMM. ... CS1 glycoprotein antigen (SLAMF7) and immunoglobulin light chains [31–35](Table1). This review summarized on-going CAR T clinical trials for multiple myeloma. hdfc evaluation